For this purpose, β1-integrin was knocked down via β1-ASO and because of its important role in inflammation and tumor progression (Rasool et al., 2021), NF-κB was knocked down as well using NF-κB-ASO. The gene discussed is NFKB1; the disease is neoplasm.